Katy Beckermann
Assistant Professor of Cell and Developmental Biology, Division of Hematology/Oncology · Vanderbilt University Medical Center
Credentials: · · · · ·
History
Research
Systematic review or meta-analysis · JAMA Oncology · 2018 · 2,273 citations
The Lancet Oncology · 2018 · 579 citations
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 571 citations
23 papers
21 papers
13 papers
11 papers
8 papers
7 papers · 4 as a fellow
7 papers
7 papers
Clinical trials
- 2018–2024
Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors
Principal investigator · Completed · Phase 1, Phase 2
Vanderbilt-Ingram Cancer Center
- 2026–2029
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Site PI · Recruiting · Phase 1
Flare Therapeutics Inc.
- 2025–2033
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Site PI · Recruiting · Phase 3
Eli Lilly and Company